81 related articles for article (PubMed ID: 27265790)
1. A novel approach to treatment in childhood acute myeloblastic leukemia and myelodysplastic syndrome with high-dose methylprednisolone as a differentiation- and apoptosis-inducing agent of myeloid leukemic cells.
Hiçsönmez G
Turk J Haematol; 2010 Mar; 27(1):1-7. PubMed ID: 27265790
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of leukemic cells induced by short-course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia.
Hiçsönmez G; Tuncer M; Toksoy HB; Yenicesu I; Cetin M
Leuk Lymphoma; 1999 May; 33(5-6):573-80. PubMed ID: 10342585
[TBL] [Abstract][Full Text] [Related]
3. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
Hiçsönmez G
Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
[TBL] [Abstract][Full Text] [Related]
4. The potential effect of short-course high-dose steroid on the maturation and apoptosis of leukemic cells in a child with acute megakaryoblastic leukemia.
Hiçsönmez G; Cetin M; Okur H; Erdemli E; Gürgey A
Leuk Lymphoma; 2003 Jun; 44(6):1037-42. PubMed ID: 12854906
[TBL] [Abstract][Full Text] [Related]
5. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
[TBL] [Abstract][Full Text] [Related]
6. Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone.
Hiçsönmez G; Erdemli E; Tekelioglu M; Tuncer AM; Ozbek N; Cetin M; Cotter TG
Leuk Lymphoma; 1996 Jun; 22(1-2):91-6,follow.186,color plate VII-III. PubMed ID: 8724533
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom.
Hiçsönmez G; Cetin M; Yenicesu I; Olcay L; Koç A; Aktaş D; Tunçbilek E; Tuncer M
Leuk Lymphoma; 2001 Aug; 42(4):665-74. PubMed ID: 11697496
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-course, high-dose steroid therapy in a child with myelodysplastic syndrome.
Hiçsönmez G; Tunç B; Olcay L; Tuncer MA
Pediatr Hematol Oncol; 2001 Dec; 18(8):525-9. PubMed ID: 11764102
[TBL] [Abstract][Full Text] [Related]
9. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment.
Hiçsönmez G; Cetin M; Tuncer AM; Yenicesu I; Aslan D; Ozyürek E; Unal S
Leuk Res; 2004 Jan; 28(1):25-34. PubMed ID: 14630077
[TBL] [Abstract][Full Text] [Related]
10. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
11. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
[TBL] [Abstract][Full Text] [Related]
12. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia.
Yildiran A; Erduran E; Tekelioğlu Y; Dilber E; Gedik Y
Turk J Pediatr; 2002; 44(2):116-21. PubMed ID: 12026198
[TBL] [Abstract][Full Text] [Related]
13. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
[TBL] [Abstract][Full Text] [Related]
14. Dramatic resolution of pleural effusion in children with chronic myelomonocytic leukemia following short-course high-dose methylprednisolone.
Hiçsönmez G; Cetin M; Tunç B; Tuncer AM; Gümrük F; Yenicesu I
Leuk Lymphoma; 1998 May; 29(5-6):617-23. PubMed ID: 9643576
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylprednisolone on human myeloid leukemic cells in vitro.
Ozbek N; Erdemli E; Hiçsönmez G; Okur H; Tekelioğlu M
Am J Hematol; 1999 Apr; 60(4):255-9. PubMed ID: 10203097
[TBL] [Abstract][Full Text] [Related]
16. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy.
Tunç B; Oner AF; Hiçsönmez G
Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371
[TBL] [Abstract][Full Text] [Related]
17. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
18. Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML.
Gandini D; De Angeli C; Aguiari G; Manzati E; Lanza F; Pandolfi PP; Cuneo A; Castoldi GL; del Senno L
Leukemia; 2002 May; 16(5):886-93. PubMed ID: 11986951
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
Özpolat B
Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
[TBL] [Abstract][Full Text] [Related]
20. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
